PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 10:22 AM ET

Sponsor Check › Person

KB
No photo found yet (own website and image search run after this page is viewed)

Kenneth Bate

Named as an officer, director or promoter on SEC Form D filings · MA · Aug 15, 2011 → Feb 8, 2021

4deals (issuers)
$375.7Mreported sold
91investors
12Form D filings
2011–2021years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:22 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Kenneth Bate is listed as a director on 12 SEC Form D filings by 4 issuers between Nov 2010 and Feb 2021: CATABASIS PHARMACEUTICALS INC (Boston, MA — pharmaceuticals — 2015–2021; $175.7M reported sold to 23 investors), GENOCEA BIOSCIENCES, INC. (Cambridge, MA — biotechnology — 2019–2020; $75.5M reported sold to 21 investors), TransMedics, Inc. (Andover, MA — other health care — 2011–2015; $63.7M reported sold to 26 investors) and AVEO PHARMACEUTICALS INC (Cambridge, MA — pharmaceuticals — 2010–2011; $60.8M reported sold to 21 investors).

What this means A repeat sponsor — 4 separate companies raised money with this person listed as director, over about 11 years. Across those companies the filings report $375.7M sold in total.

Listed alongside Earl M. Collier, Jr. (5 shared filings), Edwin M. Kania, Jr. (5 shared filings), James R. Tobin (5 shared filings), Joseph Lacob (5 shared filings), Waleed H. Hassanein (5 shared filings) and 53 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Kenneth. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — 1 bankruptcy case matching the name listed in Key records below.

What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 12 public filings for Kenneth Bate and found 9 differences, 3 worth asking the sponsor about: Regulator action naming a team member: AVEO Pharmaceuticals, Inc., et al. (Apr 4, 2019); Regulator action naming a team member: AVEO Pharmaceuticals, Inc., et al. (Mar 5, 2018); and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Kenneth Bate has not run yet — it is joining a line of 52,610 names; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:22 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Kenneth Bate..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

1 case: 1 closed (disposition not in docket feed)

Kenneth R Bate and Dawn M Bate closed
United States Bankruptcy Court, E.D. Michigan · No. 10-51105 · Filed Apr 2, 2010 · Closed Jul 19, 2010
Role of Kenneth R Bate and Dawn M Bate: Debtor · Outcome: Case closed 2010-07-19 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (rare in federal dockets); 2 people with this name in Form D filings; court in MI (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:22 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

9 differences found between the filings for Kenneth Bate — 3 worth asking about (compared 12 filings on Oct 24, 2026)

Worth asking · Apr 4, 2019

Regulator action naming a team member: AVEO Pharmaceuticals, Inc., et al. (Apr 4, 2019)

An SEC litigation release dated Apr 4, 2019 names AVEO PHARMACEUTICALS INC (related issuer). The release is the source; we do not summarize its outcome here.

What this means A regulator filed or announced an action naming this person or company (or someone on the same filings). Read the release; ask the sponsor what it was and how it ended.

AVEO Pharmaceuticals, Inc., et al. ↗AVEO PHARMACEUTICALS INC — PartnerFacts page ↗
Sources
Worth asking · Mar 5, 2018

Regulator action naming a team member: AVEO Pharmaceuticals, Inc., et al. (Mar 5, 2018)

An SEC litigation release dated Mar 5, 2018 names AVEO PHARMACEUTICALS INC (related issuer). The release is the source; we do not summarize its outcome here.

What this means A regulator filed or announced an action naming this person or company (or someone on the same filings). Read the release; ask the sponsor what it was and how it ended.

AVEO Pharmaceuticals, Inc., et al. ↗AVEO PHARMACEUTICALS INC — PartnerFacts page ↗
Sources
Worth asking · Mar 29, 2016

Regulator action naming a team member: AVEO Pharmaceuticals, Inc., et al. (Mar 29, 2016)

An SEC litigation release dated Mar 29, 2016 names AVEO PHARMACEUTICALS INC (related issuer). The release is the source; we do not summarize its outcome here.

What this means A regulator filed or announced an action naming this person or company (or someone on the same filings). Read the release; ask the sponsor what it was and how it ended.

AVEO Pharmaceuticals, Inc., et al. ↗AVEO PHARMACEUTICALS INC — PartnerFacts page ↗
Sources
Note · Jul 5, 2022 – Nov 25, 2024

Bankruptcy case: Genocea Biosciences, Inc. — filed Jul 5, 2022

United States Bankruptcy Court, D. Massachusetts docket "Genocea Biosciences, Inc." filed Jul 5, 2022, closed Nov 25, 2024. GENOCEA BIOSCIENCES, INC. (related issuer) is listed as Debtor ("Genocea Biosciences, Inc."). Our match estimate: 80%.

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, D. Massachusetts ↗GENOCEA BIOSCIENCES, INC. — PartnerFacts page ↗
Sources
Note · Jan 26, 2023 – Jan 3, 2024

Bankruptcy case: Genocea Biosciences, Inc. v. 100 Discovery Park DE, LLC — filed Jan 26, 2023

United States Bankruptcy Court, D. Massachusetts docket "Genocea Biosciences, Inc. v. 100 Discovery Park DE, LLC" filed Jan 26, 2023, closed Jan 3, 2024. GENOCEA BIOSCIENCES, INC. (related issuer) is listed as Plaintiff ("Genocea Biosciences, Inc."). Our match estimate: 80%.

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, D. Massachusetts ↗GENOCEA BIOSCIENCES, INC. — PartnerFacts page ↗
Sources
Note · Aug 5, 2011 – Aug 3, 2020

4 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — GENOCEA BIOSCIENCES, INC. (latest filing Aug 3, 2020) · No amendment in the last 12 months on an offering that may still be open — GENOCEA BIOSCIENCES, INC. (latest filing Feb 27, 2019) · No amendment in the last 12 months on an offering that may still be open — CATABASIS PHARMACEUTICALS INC (latest filing Mar 31, 2015) · No amendment in the last 12 months on an offering that may still be open — TransMedics, Inc. (latest filing Aug 15, 2011)

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Aug 3, 2020 ↗GENOCEA BIOSCIENCES, INC. — PartnerFacts page ↗Form D · Feb 27, 2019 ↗Form D · Mar 31, 2015 ↗
Sources
Note · Nov 3, 2010 – Aug 15, 2011

Kenneth Bate is written 2 different ways on the filings

listed as "Kenneth M. Bate" on 2 filings (from Nov 3, 2010), and "Kenneth Bate" on 10 filings (from Aug 15, 2011).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Nov 3, 2010 ↗Form D · Aug 15, 2011 ↗Kenneth Bate — PartnerFacts page ↗
Sources
Note · Jul 5, 2017

Same name, different state: "Kenneth M. Bate" (PA) is a separate record

This page covers filings where the address state is MA. A separate record, "Kenneth M. Bate" with address state PA, is listed on 1 filing — most recently by MADRIGAL PHARMACEUTICALS, INC. (Jul 5, 2017). Both records have filings in the same period (Jul 5, 2017).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Kenneth M. Bate (PA) — PartnerFacts page ↗Form D · Jul 5, 2017 ↗MADRIGAL PHARMACEUTICALS, INC. — PartnerFacts page ↗Kenneth Bate (MA) — this page ↗
Sources
Note · Mar 31, 2015 – Feb 8, 2021

Address moved from Cambridge, MA to Boston, MA — CATABASIS PHARMACEUTICALS INC

The people listed on the Mar 31, 2015 filing give Cambridge, MA; on the Feb 8, 2021 filing they give Boston, MA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Mar 31, 2015 ↗Form D · Feb 8, 2021 ↗CATABASIS PHARMACEUTICALS INC — PartnerFacts page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

5 of 12 offerings report sales commissions totalling $15,110,528; 0 report finder's fees; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Feb 8, 2021 D
CATABASIS PHARMACEUTICALS INC
File 021-388812
$0$0$0None listed on this filingEDGAR ↗
Feb 8, 2021 D
CATABASIS PHARMACEUTICALS INC
File 021-388817
$5,500,528$0$0Jefferies LLC BrokerCheck CRD 2347 ↗EDGAR ↗
Aug 3, 2020 D
GENOCEA BIOSCIENCES, INC.
File 021-372378
$4,790,000 (est.)$0$0STIFEL, NICOLAUS & COMPANY, INCORPORATED BrokerCheck CRD 793 ↗EDGAR ↗
Feb 27, 2019 D
GENOCEA BIOSCIENCES, INC.
File 021-333740
$750,000 (est.)$0$0None listed on this filingEDGAR ↗
Sep 21, 2015 D
TransMedics, Inc.
File 021-247946
$0$0$0None listed on this filingEDGAR ↗
Jun 4, 2015 D
TransMedics, Inc.
File 021-241112
$0$0$0None listed on this filingEDGAR ↗
Mar 31, 2015 D
CATABASIS PHARMACEUTICALS INC
File 021-236973
$0$0$0None listed on this filingEDGAR ↗
Jun 13, 2013 D
TransMedics, Inc.
File 021-197996
$0$0$0None listed on this filingEDGAR ↗
Nov 21, 2012 D
TransMedics, Inc.
File 021-187346
$425,000$0$0Piper Jaffray & Co. BrokerCheck CRD 665 ↗
via Piper Jaffray & Co. (CRD 665 ↗)
EDGAR ↗
Aug 15, 2011 D
TransMedics, Inc.
File 021-164439
$0$0$0None listed on this filingEDGAR ↗
May 31, 2011 D
AVEO PHARMACEUTICALS INC
File 021-160532
$0$0$0None listed on this filingEDGAR ↗
Nov 3, 2010 D
AVEO PHARMACEUTICALS INC
File 021-149990
$3,645,000$0$0J.P. Morgan Securities LLC BrokerCheck CRD 79 ↗
Canaccord Genuity Inc. BrokerCheck CRD 1020 ↗
RBC Capital Markets Corporation BrokerCheck CRD 31194 ↗		EDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 4

Every issuer that named Kenneth Bate on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

CP
Pharmaceuticals

CATABASIS PHARMACEUTICALS INC

Boston, MA · Mar 31, 2015 → Feb 8, 2021 · 3 filings
  • Feb 8, 2021 · D · $110,010,570 sold of $110,010,570 · 23 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 8, 2021 · D · $175,738,599 sold of $175,738,599 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 31, 2015 · D · $12,413,736 sold of $20,358,737 · 20 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $175.7M from 23 investors (100% of the $110M target) as of the latest filing. Kenneth is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

GB
Biotechnology

GENOCEA BIOSCIENCES, INC.

Cambridge, MA · Feb 27, 2019 → Aug 3, 2020 · 2 filings
  • Aug 3, 2020 · D · $75,508,015 sold of $79,877,762 · 18 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 27, 2019 · D · $12,066,763 sold of $15,002,599 · 9 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $75.5M from 21 investors (95% of the $79.9M target) as of the latest filing. Kenneth is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

T
Other Health Care

TransMedics, Inc.

Andover, MA · Aug 15, 2011 → Sep 21, 2015 · 5 filings
  • Sep 21, 2015 · D · $499,998 sold of $499,998 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 4, 2015 · D · $20,004,581 sold of $20,004,581 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 13, 2013 · D · $0 sold of $29,965,776 · 0 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 21, 2012 · D · $36,150,000 sold of $36,150,000 · 15 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 15, 2011 · D · $5,922,498 sold of $22,500,000 · 9 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $63.7M from 26 investors (100% of the $500K target) as of the latest filing. Kenneth is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AP
Pharmaceuticals

AVEO PHARMACEUTICALS INC

Cambridge, MA · Nov 3, 2010 → May 31, 2011 · 2 filings
  • May 31, 2011 · D · $7,499,997 sold of $7,499,997 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 3, 2010 · D · $60,750,000 sold of $60,750,000 · 21 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $60.8M from 21 investors (100% of the $7.5M target) as of the latest filing. Kenneth is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (1)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Kenneth M. Bate — PA, 1 issuer, Jul 5, 2017 → Jul 5, 2017 · no shared issuer

People around Kenneth 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

EK
No photo found yet (own website and image search run after this page is viewed)
Person

Edwin M. Kania, Jr.

Director · 5 shared filings (1 issuer) · also on 5 other issuers

Edwin M. Kania, Jr. is on 6 issuers in total — a repeat sponsor. Their page lists every one.

EC
No photo found yet (own website and image search run after this page is viewed)
Person

Earl M. Collier, Jr.

Director · 5 shared filings (1 issuer) · also on 6 other issuers

Earl M. Collier, Jr. is on 7 issuers in total — a repeat sponsor. Their page lists every one.

WH
No photo found yet (own website and image search run after this page is viewed)
Person

Waleed H. Hassanein

Executive Officer, Director · 5 shared filings (1 issuer)

Listed on the same filings as Kenneth Bate. Their page shows their other deals.

JL
No photo found yet (own website and image search run after this page is viewed)
Person

Joseph Lacob

Director · 5 shared filings (1 issuer)

Listed on the same filings as Kenneth Bate. Their page shows their other deals.

JT
No photo found yet (own website and image search run after this page is viewed)
Person

James R. Tobin

Director · 5 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Kenneth Bate. Their page shows their other deals.

TR
No photo found yet (own website and image search run after this page is viewed)
Person

Travis M. Rhodes

Director · 4 shared filings (1 issuer) · also on 4 other issuers

Travis M. Rhodes is on 5 issuers in total — a repeat sponsor. Their page lists every one.

TW
No photo found yet (own website and image search run after this page is viewed)
Person

Tony Lee White

Director · 4 shared filings (1 issuer)

Listed on the same filings as Kenneth Bate. Their page shows their other deals.

NG
No photo found yet (own website and image search run after this page is viewed)
Person

Nicholas Galakatos

Director · 3 shared filings (2 issuers) · also on 30 other issuers

Nicholas Galakatos is on 32 issuers in total — a repeat sponsor. Their page lists every one.

JM
No photo found yet (own website and image search run after this page is viewed)
Person

Jill Milne

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Kenneth Bate. Their page shows their other deals.

DM
No photo found yet (own website and image search run after this page is viewed)
Person

Domenic Micale

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Kenneth Bate. Their page shows their other deals.

RH
No photo found yet (own website and image search run after this page is viewed)
Person

Russell Hirsch

Director · 2 shared filings (1 issuer) · also on 11 other issuers

Russell Hirsch is on 12 issuers in total — a repeat sponsor. Their page lists every one.

RK
No photo found yet (own website and image search run after this page is viewed)
Person

Raju Kucherlapati

Director · 2 shared filings (1 issuer) · also on 5 other issuers

Raju Kucherlapati is on 6 issuers in total — a repeat sponsor. Their page lists every one.

DC
No photo found yet (own website and image search run after this page is viewed)
Person

Douglas Cole

Director · 2 shared filings (1 issuer) · also on 8 other issuers

Douglas Cole is on 9 issuers in total — a repeat sponsor. Their page lists every one.

AE
No photo found yet (own website and image search run after this page is viewed)
Person

Anthony Evnin

Director · 2 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Kenneth Bate. Their page shows their other deals.

KW
No photo found yet (own website and image search run after this page is viewed)
Person

Kenneth E. Weg

Director · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Kenneth Bate. Their page shows their other deals.

RD
No photo found yet (own website and image search run after this page is viewed)
Person

Ronald DePinho

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Kenneth Bate. Their page shows their other deals.

TN
No photo found yet (own website and image search run after this page is viewed)
Person

Tuan Ha-Ngoc

Executive Officer, Director · 2 shared filings (1 issuer)

Listed on the same filings as Kenneth Bate. Their page shows their other deals.

MH
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Higgins

Director · 2 shared filings (1 issuer) · also on 7 other issuers

Michael Higgins is on 8 issuers in total — a repeat sponsor. Their page lists every one.

KB
No photo found yet (own website and image search run after this page is viewed)
Person

Katrine Bosley

Director · 2 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Kenneth Bate. Their page shows their other deals.

GS
No photo found yet (own website and image search run after this page is viewed)
Person

George Siber

Director · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Kenneth Bate. Their page shows their other deals.

DA
No photo found yet (own website and image search run after this page is viewed)
Person

David C. Abrams

Director · 2 shared filings (1 issuer) · also on 9 other issuers

David C. Abrams is on 10 issuers in total — a repeat sponsor. Their page lists every one.

DJ
No photo found yet (own website and image search run after this page is viewed)
Person

David Johnston

Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Kenneth Bate. Their page shows their other deals.

RY
No photo found yet (own website and image search run after this page is viewed)
Person

Robert C. Young

Director · 2 shared filings (1 issuer)

Listed on the same filings as Kenneth Bate. Their page shows their other deals.

WS
No photo found yet (own website and image search run after this page is viewed)
Person

William Slichenmyer

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Kenneth Bate. Their page shows their other deals.

JG
No photo found yet (own website and image search run after this page is viewed)
Person

Jeno Gyuris

Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Kenneth Bate. Their page shows their other deals.

JF
No photo found yet (own website and image search run after this page is viewed)
Person

JESSICA BAKER FLECHTNER

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Kenneth Bate. Their page shows their other deals.

WC
No photo found yet (own website and image search run after this page is viewed)
Person

WILLIAM CLARK

Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Kenneth Bate. Their page shows their other deals.

DA
No photo found yet (own website and image search run after this page is viewed)
Person

David Abram

Director · 2 shared filings (1 issuer)

Listed on the same filings as Kenneth Bate. Their page shows their other deals.

SG
No photo found yet (own website and image search run after this page is viewed)
Person

Stephen Gordon

Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Kenneth Bate. Their page shows their other deals.

AB
No photo found yet (own website and image search run after this page is viewed)
Person

Ali Behbahani

Director · 2 shared filings (1 issuer) · also on 5 other issuers

Ali Behbahani is on 6 issuers in total — a repeat sponsor. Their page lists every one.

GA
No photo found yet (own website and image search run after this page is viewed)
Person

Girish Aakalu

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Kenneth Bate. Their page shows their other deals.

RC
No photo found yet (own website and image search run after this page is viewed)
Person

Ronald Cooper

Director · 2 shared filings (1 issuer)

Listed on the same filings as Kenneth Bate. Their page shows their other deals.

TD
No photo found yet (own website and image search run after this page is viewed)
Person

Thomas Davis

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Kenneth Bate. Their page shows their other deals.

HM
No photo found yet (own website and image search run after this page is viewed)
Person

Howard Mayer

Director · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Kenneth Bate. Their page shows their other deals.

JV
No photo found yet (own website and image search run after this page is viewed)
Person

Jonathan Violin

Director · 2 shared filings (1 issuer) · also on 5 other issuers

Jonathan Violin is on 6 issuers in total — a repeat sponsor. Their page lists every one.

HC
No photo found yet (own website and image search run after this page is viewed)
Person

Hugh Cole

Director · 2 shared filings (1 issuer)

Listed on the same filings as Kenneth Bate. Their page shows their other deals.

JD
No photo found yet (own website and image search run after this page is viewed)
Person

Joanne Donovan

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Kenneth Bate. Their page shows their other deals.

AN
No photo found yet (own website and image search run after this page is viewed)
Person

Andrew Nichols

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Kenneth Bate. Their page shows their other deals.

AK
No photo found yet (own website and image search run after this page is viewed)
Person

Andrew Komjathy

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Kenneth Bate. Their page shows their other deals.

MK
No photo found yet (own website and image search run after this page is viewed)
Person

Michael D. Kishbauch

Director · 2 shared filings (1 issuer)

Listed on the same filings as Kenneth Bate. Their page shows their other deals.

Registrations and other filings

Business registration (state registry / Secretary of State)

Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

Adviser registration (Form ADV)

None of the 4 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records 1 records on 1 issuer

Property records are matched to companies only, never to individuals, so none are matched to Kenneth Bate by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 4 issuers this person is listed on — 1 issuer has property records: TransMedics, Inc. (1).

Public profiles and social

Websites and social links of the issuers Kenneth Bate is listed on: none on file. No website or social profile named in AVEO PHARMACEUTICALS INC's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #351,108 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Cambridge, MA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗Massachusetts MassCourts ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

Massachusetts Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Kenneth Bate appears on a new Form D, or when a court case or SEC action is matched to them. See plans →